Tunbridge Court
Tunbridge Lane Bottisham
Cambridge CB25 9TU
United Kingdom
44 1223 810 700
https://www.cambridgecognition.com
Sector(s): Healthcare
Industry: Health Information Services
Full-time employees: 80
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Dr. Matthew William Stork | CEO & Director | 342k | N/A | 1968 |
Mr. John Hammond | Co-Founder | N/A | N/A | N/A |
Mr. Nick Taptiklis | Head of Technology Strategy | N/A | N/A | N/A |
Ms. Francesca Cormack Ph.D. | Chief Scientist & Member of Scientific Advisory Board | N/A | N/A | N/A |
Mr. Simon Merritt | Marketing and Communications Director | N/A | N/A | N/A |
Dr. Lisa Elizabeth Nolan Ph.D. | Vice President Business Development | N/A | N/A | 1962 |
Ms. Nicky Ackerley | Global HR Director | N/A | N/A | N/A |
Prof. Trevor Robbins CBE, FBPsS, FMedSci, FRS, Ph.D. | Senior Consultant | N/A | N/A | N/A |
Prof. Barbara Sahakian FBPsS, FMedSci | Senior Consultant | N/A | N/A | N/A |
Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB digital cognitive assessment platform for drug development by enabling pharmaceutical companies to take new therapeutics from preclinical consultancy to pivotal studies and approval, as well as supports sponsors to enhance recruitment, develop safe and effective treatments, and enhance research and development efficiency. It also provides CANTAB Connect Research, a proprietary platform that provides insights into behaviours, underlying brain circuits, and measurement of digital cognitive biomarkers; CANTAB Mobile, a touchscreen assessment of memory, mood, and functional status to detect the earliest signs of clinically relevant memory problems; CANTAB Insight to assess cognitive health; and CANTAB BrainHealth for assessing workplace wellbeing. In addition, the company offers electronic questionnaires and scales, a digital bespoke questionnaire; NeuroVocalix, a voice analysis platform to analyze voice to assess neurological change; cognition kit, a high frequency testing kit to detect changes over time and day-to-day cognition with short regular tests using patients' own devices. Cambridge Cognition Holdings Plc was incorporated in 2012 and is based in Cambridge, the United Kingdom.
Cambridge Cognition Holdings Plc’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.